The impact of perioperative atelectasis on antibiotic penetration into lung tissue: An in vivo microdialysis study

Intensive Care Medicine

Volumn 34, Issue 10, 2008, Pages 1827-1834

  Hutschala, Doris ^a   Kinstner, Christian ^a   Skhirtladze, Keso ^a   Mayer Helm, Bernhard Xaver ^a   Zeitlinger, Markus ^a   Wisser, Wilfried ^a   Müller, Markus ^a   Tschernko, Edda ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antibiotic; Atelectasis formation; Cardiac surgery; Concentration; Lung tissue; Microdialysis

Indexed keywords

ANTIBIOTIC AGENT; LEVOFLOXACIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; AREA UNDER THE CURVE; ARTICLE; ATELECTASIS; ATTRIBUTABLE RISK; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG TISSUE LEVEL; HUMAN; IN VIVO STUDY; LUNG PARENCHYMA; LUNG PERFUSION; LUNG VENTILATION; MICRODIALYSIS; OFF PUMP CORONARY SURGERY; PNEUMONIA; POSTOPERATIVE INFECTION; PROSPECTIVE STUDY;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CORONARY ARTERY BYPASS; CORONARY ARTERY BYPASS, OFF-PUMP; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; MICRODIALYSIS; MIDDLE AGED; OFLOXACIN; PNEUMONIA; POSTOPERATIVE CARE; PULMONARY ATELECTASIS;

EID: 52949133403     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-008-1122-8     Document Type: Article

References (29)

1. BA Cunha 2001 Nosocomial pneumonia. Diagnostic and therapeutic considerations Med Clin North Am 85 79 114
2. RE Ariano GG Zhanel 1991 Antimicrobial prophylaxis in coronary bypass surgery: a critical appraisal Drug Intell Clin Pharm 25 478 484
3. E Stahle A Tammelin R Bergstrom A Hambreus SO Nystrom HE Hansson 1997 Sternal wound complications-incidence, microbiology and risk factors Eur J Cardiothorac Surg 11 1146 1153
4. T Carrel ER Schmid L von Segesser M Vogt M Turina 1991 Perioperative assessment of the likelihood of infection of the lower respiratory tract after cardiac surgery Thorac Cardiovasc Surg 39 85 88
5. M Brunner T Pernersdorfer B Mayer HG Eichler M Müller 2000 Surgery and intensive care procedures affect the target site distribution of piperacillin Crit Care Med 28 1754 1759
6. C Joukhadar M Frossard BX Mayer HG Eichler M Müller 2001 Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock Crit Care Med 29 385 391
7. JM Hyatt PS McKinnon GS Zimmer JJ Schentag 1995 The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents Clin Pharmacokinet 28 143 160
8. EM Tschernko A Bambazek Wisser E Wolner 2002 Intrapulmonary shunt after cardiopulmonary bypass: the use of vital capacity maneuvers versus off-pump coronary artery bypass grafting J Thorac Cardiovasc Surg 124 732 738
9. KC Kirk RA Aldridge JJ Sistino 2001 Coronary artery bypass grafting with and without cardiopulmonary bypass: a comparison analysis J Extra Corpor Technol 33 86 90
10. T Yokoyama FJ Baumgartner A Gheissari ER Capouya GP Panagiotides RJ Declusin 2001 Off-pump versus on-pump coronary bypass in high-risk subgroups Ann Thorac Surg 70 1546 1550
11. M Müller O Haag T Burgdorff 1996 Characterisation of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in human Antimicrob Agents Chemother 40 2703 2709
12. C Joukhadar H Derendorf M Müller 2001 Microdialysis, a novel tool for clinical studies of anti-infective agents Eur J Clin Pharmacol 57 211 219
13. U Neckel C Joukhadar M Frossard W Jäger M Müller BX Mayer 2000 Simultaneous determination of levofloxacin and ciprofloxacin in microdialysates and plasma by high-performance liquid chromatography Anal Chim Acta 463 199 206
14. R Cartier 2003 Current trends and technique in OPCAB surgery J Card Surg 18 32 46
15. C Detter H Reichenspumer DH Boehm 2002 Minimally invasive direct coronary artery bypass grafting (MIDCAB) and off-pump coronary artery bypass grafting (OPCAB): two techniques for beating heart surgery Heart Surg Forum 5 157 162
16. A Georgopoulos A Buxbaum U Straschil W Granninger 1998 Austrian national survey of prevalence of antimicrobial resistance among clinical isolates of Streptococcus pneumoniae 1994-1996 Scand J Infect Dis 30 345 349
17. DH Wright GH Brown ML Paterson JC Rotschafter 2000 Application of fluoroquinolone pharmacodynamics J Antimicrob Agents Chemother 46 669 683
18. DM Ryan 1993 Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans J Antimicrob Chemother 31 Suppl D 1 16
19. HG Eichler M Müller 1998 Drug distribution. The forgotten relative in clinical pharmacokinetics Clin Pharmacokinet 34 95 99
20. MJ Kennedy A Van Riji 1998 Effects of surgery on the pharmacokinetic parameters of drugs Clin Pharmacokinet 35 293 312
21. M Brunner T Pernerstorfer BX Mayer HG Eichler M Müller 2000 Surgery and intensive care procedures affect the target site distribution of piperacillin Crit Care Med 28 1754 1759
22. D Hutschala K Skhirdlatze A Zuckermann W Wisser E Wolner E Tschernko 2005 In vivo measurement of levofloxacin penetration into lung tissue after cardiac surgery Antimicrob Agents Chemother 49 5107 5111
23. M Müller R Schmid A Georgopoulos A Buxbaum C Wasicek HG Eichler 1995 Application of microdialysis to clinical pharmacokinetics in humans Clin Pharmacol Ther 57 371 380
24. FDA. Guidance for industry. Developing antimicrobial drugs - general considerations for clinical trials. http://www.fda.gov/cder/guidance/2580dft.pdf
25. Department of Health and Human Service, Food and Drug Administration (1989) Guidance documents on developing antimicrobial drugs. Anti-infective drugs advisory committee meeting, 64th meeting, vol 496. Miller Reporting Co., Washington DC, pp 167-179
26. F Tomaselli P Dittrich A Maier 2003 Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis Br J Clin Pharmacol 55 620 624
27. F Tomaselli A Maier V Matzi FM Smolle-Jüttner P Dittrich 2004 Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis Antimicrob Agents Chemother 48 2228 2232
28. GJ Noel DB Goodman S Chien B Solanki M Padmanabhan 2004 Measuring the effects of supratherapeutic doses of levofloxacin on healthy volunteers using four methods correction and periodic and continuous ECG recording J Clin Pharmacol 44 464 473
29. CM Fogarty JG Sullivan MS Chattman 1998 Once a day levofloxacin in the treatment of mild to moderate and severe community-acquired pneumonia in adults Infect Dis Clin Pract 7 400 407